Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

出版年份 2010 全文链接

标题

作者

关键词

出版物

Volume 376, Issue 9737, Pages 235-244

出版商

Elsevier BV

发表日期

2010-07-07

DOI

10.1016/s0140-6736(10)60892-6

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation